Stoneridge (SRI) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
2 Dec, 2025Executive summary
The 2025 Annual Meeting will be held virtually on May 13, 2025, to elect seven directors, ratify Ernst & Young LLP as auditor, approve executive compensation on a non-binding basis, and approve a new Long-Term Incentive Plan (LTIP).
Shareholders of record as of March 21, 2025, are eligible to vote, with each share entitled to one vote per proposal.
2024 net sales decreased by 6.9% to $908.3 million, with operating income declining and net loss increasing due to lower sales and higher interest expense.
Voting matters and shareholder proposals
Proposals include election of seven directors, auditor ratification, advisory say-on-pay, and approval of the 2025 LTIP.
Board recommends voting FOR all proposals.
Shareholder proposals for the 2026 meeting must be received by December 4, 2025, for inclusion in proxy materials.
Board of directors and corporate governance
Board will be reduced from nine to seven members at the meeting; six of seven nominees are independent.
Board committees include Audit, Compensation, Nominating and Corporate Governance, and Compliance and Ethics, all composed of independent directors.
Annual board and committee self-assessments are conducted.
Board diversity matrix discloses gender and ethnic diversity.
Shareholders have the right to communicate directly with the Board.
Latest events from Stoneridge
- 2025 outperformed end markets with 69%–70% MirrorEye growth and strong 2026 targets.SRI
Q4 202512 Mar 2026 - Q2 2024 saw margin gains, EPS growth, and updated guidance as key tech launches accelerated.SRI
Q2 20242 Feb 2026 - Control Devices sold for $59M to focus on advanced electronics and reduce debt.SRI
Status update2 Feb 2026 - MirrorEye and Smart 2 drive growth through innovation, safety, and regulatory compliance.SRI
CL King’s 22nd Annual Best Ideas Conference 202420 Jan 2026 - Q3 sales and earnings declined, but cash flow and MirrorEye adoption showed improvement.SRI
Q3 202417 Jan 2026 - Growth driven by MirrorEye, Smart 2, and operational improvements despite market softness.SRI
Stephens 26th Annual Investment Conference | NASH202413 Jan 2026 - MirrorEye/Mirai and Smart 2 growth offset market declines, driving margin and cash flow gains.SRI
Q4 202426 Dec 2025 - Margin gains and record product sales drive Q1, with guidance reaffirmed despite net loss.SRI
Q1 202524 Dec 2025 - Shareholders to vote on a new incentive plan consolidating all future equity awards.SRI
Proxy Filing2 Dec 2025